Literature DB >> 22278740

Insilico study of the A(2A)R-D (2)R kinetics and interfacial contact surface for heteromerization.

Amresh Prakash1, Pratibha Mehta Luthra.   

Abstract

G-protein-coupled receptors (GPCRs) are cell surface receptors. The dynamic property of receptor-receptor interactions in GPCRs modulates the kinetics of G-protein signaling and stability. In the present work, the structural and dynamic study of A(2A)R-D(2)R interactions was carried to acquire the understanding of the A(2A)R-D(2)R receptor activation and deactivation process, facilitating the design of novel drugs and therapeutic target for Parkinson's disease. The structure-based features (Alpha, Beta, SurfAlpha, and SurfBeta; GapIndex, Leakiness and Gap Volume) and slow mode model (ENM) facilitated the prediction of kinetics (K (off), K (on), and K (d)) of A(2A)R-D(2)R interactions. The results demonstrated the correlation coefficient 0.294 for K (d) and K (on) and the correlation coefficient 0.635 for K (d) and K (off), and indicated stable interfacial contacts in the formation of heterodimer. The coulombic interaction involving the C-terminal tails of the A(2A)R and intracellular loops (ICLs) of D(2)R led to the formation of interfacial contacts between A(2A)R-D(2)R. The properties of structural dynamics, ENM and KFC server-based hot-spot analysis illustrated the stoichiometry of A(2A)R-D(2)R contact interfaces as dimer. The propensity of amino acid residues involved in A(2A)R-D(2)R interaction revealed the presence of positively (R, H and K) and negatively (E and D) charged structural motif of TMs and ICL3 of A(2A)R and D(2)R at interface of dimer contact. Essentially, in silico structural and dynamic study of A(2A)R-D(2)R interactions will provide the basic understanding of the A(2A)R-D(2)R interfacial contact surface for activation and deactivation processes, and could be used as constructive model to recognize the protein-protein interactions in receptor assimilations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278740     DOI: 10.1007/s00726-012-1218-x

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

Review 1.  Minireview: applied structural bioinformatics in proteomics.

Authors:  Yee Siew Choong; Gee Jun Tye; Theam Soon Lim
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

2.  Identifying the Novel Inhibitors Against the Mycolic Acid Biosynthesis Pathway Target "mtFabH" of Mycobacterium tuberculosis.

Authors:  Niranjan Kumar; Rakesh Srivastava; Raj Kumar Mongre; Chandra Bhushan Mishra; Amit Kumar; Rosy Khatoon; Atanu Banerjee; Md Ashraf-Uz-Zaman; Harpreet Singh; Andrew M Lynn; Myeong-Sok Lee; Amresh Prakash
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

3.  Targeting virus-host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19.

Authors:  Jitendra Subhash Rane; Preeti Pandey; Aroni Chatterjee; Rajni Khan; Abhijeet Kumar; Amresh Prakash; Shashikant Ray
Journal:  J Biomol Struct Dyn       Date:  2020-07-20

Review 4.  Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Authors:  Kavya Prasad; Erik F J de Vries; Philip H Elsinga; Rudi A J O Dierckx; Aren van Waarde
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

5.  Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach.

Authors:  Satabdi Saha; Rajat Nandi; Poonam Vishwakarma; Amresh Prakash; Diwakar Kumar
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

6.  Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development.

Authors:  Preeti Pandey; Jitendra Subhash Rane; Aroni Chatterjee; Abhijeet Kumar; Rajni Khan; Amresh Prakash; Shashikant Ray
Journal:  J Biomol Struct Dyn       Date:  2020-07-22

7.  "Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CLpro and PLpro."

Authors:  Deep Bhowmik; Ravi Datta Sharma; Amresh Prakash; Diwakar Kumar
Journal:  J Mol Struct       Date:  2021-02-15       Impact factor: 3.196

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.